US Patent Issued to JRX Biotechnology on April 29 for "Liquid topical pharmaceutical nano-emulsion formulations" (California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,487, issued on April 29, was assigned to JRX Biotechnology Inc. (Newport Beach, Calif.).

"Liquid topical pharmaceutical nano-emulsion formulations" was invented by Frederick L. Jordan (Santa Ana, Calif.) and Chris Jordan (Santa Ana, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the present invention are directed to compositions that are useful for delivery of an active ingredient to a subject. Some embodiments are formulated with an active ingredient, including, for example, a non-steroidal anti-inflammatory drug (NSAID), such as aspirin, ibuprofen, ketoprofen, or naproxen, acetaminophen, or a polypeptide or protein, such as insuli...